OSAPQ — ProSomnus Share Price
0.000.00%
Last trade - 00:00- $0.12m
- $27.47m
- $27.65m
- 17
- 64
- 12
- 22
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.01 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -92.84% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 8.29 | 14.07 | 19.39 | 27.65 | 34.19 | 42.73 | 49.44% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ProSomnus, Inc. is a medical technology company. The Company is focused on the development, manufacturing and marketing of precision intraoral medical devices, a novel non-invasive option for treating and managing patients with obstructive sleep apnea (OSA). Its intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. The Company's devices have demonstrated efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. Its precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government-sponsored healthcare plans around the world, representing over 200 million covered lives. The Company’s products include ProSomnus EVO Sleep and Snore Device, ProSomnus EVO SELECT Sleep and Snore Device, ProSomnus EVO [PH] Sleep and Snore Device, ProSomnus [CA] LP Sleep and Snore Device and ProSomnus [MOG] Morning Occlusal Guide.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- May 3rd, 2022
- Public Since
- June 15th, 2021
- No. of Shareholders
- 363
- No. of Employees
- 136
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 17,394,064
- Address
- 5675 Gibraltar Dr, PLEASANTON, 94588
- Web
- https://prosomnus.com/
- Phone
- Auditors
- Marcum LLP
Upcoming Events for OSAPQ
Similar to OSAPQ
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
What is the ProSomnus share price?
As of Today at 22:46 UTC, shares in ProSomnus are trading at $0.01. This share price information is delayed by 15 minutes.
How has the ProSomnus share price performed this year?
Shares in ProSomnus last closed at $0.01 and the price had moved by -99.75% over the past 365 days. In terms of relative price strength the ProSomnus share price has underperformed the S&P500 Index by -99.79% over the past year.
What are the analyst and broker recommendations for ProSomnus?
The overall consensus recommendation for ProSomnus is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the ProSomnus dividend yield?
ProSomnus does not currently pay a dividend.
Does ProSomnus pay a dividend?
ProSomnus does not currently pay a dividend.
When does ProSomnus next pay dividends?
ProSomnus does not currently pay a dividend.
How do I buy ProSomnus shares?
To buy shares in ProSomnus you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of ProSomnus?
As of the previous close price of $0.01, shares in ProSomnus had a market capitalisation of $0.17m.
Where are ProSomnus shares listed?
Here are the trading details for ProSomnus:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: OSAPQ
What kind of share is ProSomnus?
Based on an overall assessment of its quality, value and momentum ProSomnus is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a ProSomnus share price forecast for 2024?
The analyst consensus target price for shares in ProSomnus is $3.00. That is 29900% above the last closing price of $0.01.
Analysts covering ProSomnus currently have a consensus Earnings Per Share (EPS) forecast of -$1.10 for the next financial year.
What is the trend in the ProSomnus share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ProSomnus. Over the past six months, its share price has underperformed the S&P500 Index by -98.99%.
As of the last closing price of $0.01, shares in ProSomnus were trading -98.3% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the ProSomnus PE Ratio?
The ProSomnus PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of ProSomnus?
We do not have data on ProSomnus' directors